C2488
Citrate Buffer Solution, 0.09 M
Synonym(s):
Citric Acid Buffer Solution
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
12161700
NACRES:
NA.25
eCl@ss:
32129211
Quality Level
description
Contains 1% chloroform, pH 4.8 at 25 °C.
form
solution
concentration
0.09 M
pH
4.8 (25 °C)
application(s)
diagnostic assay manufacturing
storage temp.
2-8°C
General description
Citrate Buffer Solution, 0.09 M, is a high-quality biochemical buffer solution commonly employed in various research applications. Its applications include use in acid phosphatase reactions alongside p-nitrophenyl phosphate (pNPP) enzyme substrate. Citrate Buffer is also used for the isolation of RNA from cells and tissues. In addition, it is also used as a background electrolyte for separating sulfonamides utilizing capillary zone electrophoresis. With its superior buffering capacity and ability to maintain a stable pH, Citrate Buffer Solution, 0.09 M is an excellent choice for any researcher in need of reliable performance.
Application
Citrate Buffer Solution, 0.09 M has been used as a heat-induced antigen retriever on formalin-fixed paraffin-embedded (FFPE) tissue sections during immunohistochemistry (IHC) experiments. It has also been used in the preparation of hybridization solutions for fluorescence in situ hybridization (FISH) procedures.
Other Notes
Unit definition: One unit of acid phosphatase will hydrolyze 1.0 μmole of p-nitrophenyl phosphate per, minute at pH 4.8 at 37 °C.
signalword
Warning
hcodes
Hazard Classifications
Carc. 2 - STOT RE 2 Oral
target_organs
Liver,Kidney
Storage Class
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Regulatory Information
易制毒化学品（2类）
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Argyrios G Daskalopoulos et al.
Oral surgery, oral medicine, oral pathology and oral radiology, 129(5), 493-513 (2020-03-17)
Toll-like receptors (TLRs) may promote or inhibit tumor progression. The aim of this study was to assess the expression of TLR4 and TLR9 and their downstream targets in oral tongue squamous cell carcinoma (OTSCC) in correlation with histopathologic parameters and
Nikolaos G Nikitakis et al.
Oral surgery, oral medicine, oral pathology and oral radiology, 125(2), 164-171 (2017-12-19)
Primary oral malignant melanoma (POMM) is a rare type of malignancy with a very poor prognosis, the molecular pathogenesis of which remains elusive. The aim of this study was to assess the expression status of signal transducer and activator of
Greg C Bristow et al.
Cell reports, 31(3), 107536-107536 (2020-04-23)
Chromosome 16p11.2 duplications dramatically increase risk for schizophrenia, but the mechanisms remain largely unknown. Here, we show that mice with an equivalent genetic mutation (16p11.2 duplication mice) exhibit impaired hippocampal-orbitofrontal and hippocampal-amygdala functional connectivity. Expression of schizophrenia-relevant GABAergic cell markers
Global Trade Item Number
| SKU | GTIN |
|---|---|
| C2488-100ML | 04061838254962 |
| C2488-500ML | 04061833477892 |